Monthly Archives: November 2009

ASH ’09 Sneak Preview

ASH ’09 Sneak PreviewImmediately below is an American Society of Hematology Sneak Preview highlighting some of the more compelling data announcements at this year’s ASH meeting. The information below is brought to you by the publisher of The Medical Technology Stock Letter (MTSL), John McCamant, (www.bioinvest.com). The information published here is not a recommendation, and [...]

GenVec receives Orphan Drug status for TNFerade

In a new feature for OBR readers, we will occasionally get updates relevant to recent oncology headlines or upcoming oncology events from John McCamant, publisher of The Medical Technology Stock Letter (www.bioinvest.com). The information published here is not a recommendation, and is provided for informational purposes only. GenVec’s stock is up as much as 25% [...]